Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 201 to 210 of 1525

TitleReference numberPublishedLast updated
Empagliflozin for treating chronic kidney diseaseTA942
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)TA940
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)TA941
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesTA943
Risdiplam for treating spinal muscular atrophyTA755
Transition from children's to adults' servicesQS140
Digitally enabled therapies for adults with anxiety disorders: early value assessmentHTG676
Middle meningeal artery embolisation for chronic subdural haematomasHTG706
Cardiovascular disease: risk assessment and reduction, including lipid modificationNG238
Velmanase alfa for treating alpha-mannosidosisHST29

Results per page

  1. 10
  2. 25
  3. 50
  4. All